Sudhir Sivakumaran, PhD

Sudhir Sivakumaran, PhD, is Chief Scientific Officer of the Lewy Body Dementia Association, where he leads scientific strategy, translational research, and cross-sector partnerships to accelerate therapeutic development in neurodegenerative disease. He brings more than two decades of experience across academia, biotechnology, pharmaceutical R&D, and nonprofit leadership, with expertise spanning translational neuroscience, biomarkers, clinical development, regulatory science, and data-driven evidence generation. Previously, he served as Executive Director of the Critical Path for Alzheimer’s Disease consortium and Vice President of the Neuroscience Program at the Critical Path Institute and held scientific and leadership roles at Pfizer and Aptinyx, among others. His work focuses on bridging scientific discovery and clinical development through biomarker strategy, data integration, trial optimization, regulatory engagement, and public-private collaboration. He holds a PhD in Neuroscience and has authored numerous peer-reviewed publications.